Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease

• Egile Nagusiak: Aswine K. Bal (Egilea), Deepa Prasad (Egilea), Maria Angela Umali Pamintuan (Egilea), Elizabeth Mammen-Prasad (Egilea), Anna Petrova (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2014-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Kawasaki disease (KD) is a type of febrile self-limiting systemic vasculitis, which affects the coronary arteries (CA) and may cause cardiac ischemia during childhood and adult life. Intravenous immunoglobulin (IVIG) has become the standard therapy for KD. However, it is still uncertain if CA outcom...